https://www.youtube.com/watch?v=QnmnyZ14A4wIn health systems, although there are many stakeholders with different interests (healthcare practitioners, policymakers, industry, patients and the public), many share the value of better health for all. However, when a decision needs to be made, it is not

The North Eastern Region (NER) of India is strengthening its capacity in Health Economics and Health Technology Assessment (HTA), and to generate and use evidence to inform equitable and efficient health policy and resource allocation.This programme of work, in collaboration with IIPH Shillong and the Ministry of Health and Family Welfare, Meghalay

The healthcare sector contributes to greenhouse gas emissions through the use of energy, water, medical products, and waste management. Kidney replacement therapy is particularly resource-intensive, requiring substantial amounts of consumables, electricity, water, transportation, and waste treatment throughout a patient\'s lifetime. However, eviden

The Standard Cost List for Health Technology Assessment in Thailand provides the foundational cost data for Health Technology Assessment (HTA) and economic evaluation studies. It supplies robust, context-specific cost data to inform evidence-based policy, specifically for developing and revising benefit packages under Thailand’s Universal Coverag

Abstract Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secur

The research and development of new medicines is a lengthy and sequential process that spans more than a decade, culminating in regulatory approval based on evidence of quality, safety, and efficacy from clinical trial data. In Thailand, it takes nearly an additional decade for new medicines to be included in the Thailand National List of Essential

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le

Tuberculosis is caused by bacterium called Mycobacterium tuberculosis. It is a significant problem in Thailand as seen that in 2021 Thailand is in the World Health Organization’s list of 30 high-burden countries for tuberculosis. One of the problems about tuberculosis is inaccurate diagnosis due to insufficient sensitivity and specificity of prim

The development of medical innovation is one of Thailand’s key strategic priorities, as outlined in the 13th National Economic and Social Development Plan (2023–2027), with Milestone 4 positioning Thailand as a hub for high-value medical and healthcare services. However, Thailand’s research and development in medical technologies and health i

The project aims to evaluate the cost-effectiveness, economic impact, and feasibility of integrating this herbal innovation into Thailand’s healthcare system. By applying Early HTA techniques, this study will provide insights for decision-makers, improve resource allocation, and support future investments in innovative medical solutions.67301075M